MAYbe someday something simuilar..
On Wednesday, Cramer will be focused on the IPO of Calithera Biosciences. "It has very similar characteristics to Agios Pharmaceuticals (AGIO), a stock that rallied $10 today on news that its breakthrough blood cancer drug might have some very good phase one results," Cramer said. "Calithera has a similar method of killing blood cancers that will certainly pique investors' interests because it sounds so much like Agios."
SJO
Never buy/sell based on my posts.My posts are opinions
only.My positions are subject to change W/O
notice NOTICE: NSA reportedly monitors,copies,and
captures IP address of electronic communications to and from the USA.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
